Waist-to-Height Ratio

Biomarker

Related News

GLP-1 Weight Loss Injections Show Significant Results in Clinical Studies

Feb 14, 2026

Clinical studies demonstrate GLP-1 receptor agonists like semaglutide and tirzepatide produce substantial weight loss when combined with lifestyle changes, with patients achieving mean reductions of 14.9% body weight over 68 weeks.

Obesity Linked to 1 in 4 Infectious Disease Deaths in U.S., 1 in 10 Globally

Feb 11, 2026

Obesity contributes to about 1 in every 4 infectious disease deaths in the United States and 1 in 10 globally, according to a major study. People with obesity face 70% higher risk of hospitalization or death from infections, with risk tripling at severe obesity levels.